A cytokine-controlled mechanism for integrated regulation of T-lymphocyte motility, adhesion and activation

Immunology

Volumn 140, Issue 4, 2013, Pages 441-455

  Bergström, Sten Erik ^a,b   Bergdahl, Eva ^a   Sundqvist, Karl Gösta ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Lipoprotein receptor related protein 1; Lymphocytes; MHC; Migration; Thrombospondin 1

Indexed keywords

CALRETICULIN; CD3 ANTIGEN; CD47 ANTIGEN; FIBRONECTIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2; INTERLEUKIN 4; JANUS KINASE; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; T LYMPHOCYTE RECEPTOR; THROMBOSPONDIN 1;

ANTIGEN EXPRESSION; ARTICLE; CELL ADHESION; CELL MOTILITY; CELL MOTION; CELL SHAPE; CELL STIMULATION; CELL SURFACE; CONTROLLED STUDY; DNA SYNTHESIS; GENE SILENCING; GENETIC TRANSFECTION; HELPER CELL; HUMAN; LIGAND BINDING; LYMPHOCYTE PROLIFERATION; MOLECULAR INTERACTION; NONHUMAN; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; UPREGULATION; WESTERN BLOTTING;

LIPOPROTEIN RECEPTOR-RELATED PROTEIN 1; LYMPHOCYTES; MHC; MIGRATION; THROMBOSPONDIN-1;

ANTIGENS, CD3; ANTIGENS, CD47; CALRETICULIN; CELL ADHESION; CELL PROLIFERATION; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; FIBRONECTINS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-2; INTERLEUKIN-4; JANUS KINASES; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-1; LYMPHOCYTE ACTIVATION; RECEPTORS, ANTIGEN, T-CELL; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; T-LYMPHOCYTES; THROMBOSPONDIN 1; TIME FACTORS; TRANSFECTION;

EID: 84886603040     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12154     Document Type: Article

References (61)

1. Dustin ML. Stop and go traffic to tune T cell responses. Immunity 2004; 21:305-14.
2. Hershko AY, Suzuki R, Charles N, Alvarez-Errico D, Sargent JL, Laurence A, Rivera J. Mast cell interleukin-2 production contributes to suppression of chronic allergic dermatitis. Immunity 2011; 35:562-71.
3. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993; 75:253-61.
4. Suzuki H, Kundig TM, Furlonger C et al. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor β. Science 1995; 268:1472-6.
5. Barron L, Dooms H, Hoyer KK, Kuswanto W, Hofmann J, O'Gorman WE, Abbas AK. Cutting edge: mechanisms of IL-2-dependent maintenance of functional regulatory T cells. J Immunol 2012; 185:6426-30.
6. Malek TR, Yu A, Vincek V, Scibelli P, Kong L. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rβ-deficient mice. Implications for the nonredundant function of IL-2. Immunity 2002; 17:167-78.
7. Webster KE, Walters S, Kohler RE, Mrkvan T, Boyman O, Surh CD, Grey ST, Sprent J. In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression. J Exp Med 2009; 206:751-60.
8. Pryce G, Male D, Campbell I, Greenwood J. Factors controlling T-cell migration across rat cerebral endothelium in vitro. J Neuroimmunol 1997; 2:84-94.
9. Wilkinson PC, Newman I. Chemoattractant activity of IL-2 for human lymphocytes: a requirement for the IL-2 receptor β-chain. Immunology 1994; 82:134-9.
10. Woolf E, Grigorova I, Sagiv A et al. Lymph node chemokines promote sustained T lymphocyte motility without triggering stable integrin adhesiveness in the absence of shear forces. Nat Immunol 2007; 8:1076-85.
11. Gao AG, Lindberg FP, Finn MB, Blystone SD, Brown EJ, Frazier WA. Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin. J Biol Chem 1996; 271:21-4.
12. Tan K, Duquette M, Liu JH, Zhang R, Joachimiak A, Wang JH, Lawler J. The structures of the thrombospondin-1 N-terminal domain and its complex with a synthetic pentameric heparin. Structure 2006; 14:33-42.
13. 1 integrin. J Biol Chem 2003; 278:40679-87.
14. Goicoechea S, Pallero MA, Eggleton P, Michalak M, Murphy-Ullrich JE. The anti-adhesive activity of thrombospondin is mediated by the N-terminal domain of cell surface calreticulin. J Biol Chem 2002; 277:37219-28.
15. 1 integrin and CD47 differentially modulate T cell behavior. J Cell Biol 2002; 157:509-19.
16. Orr AW, Elzie CA, Kucik DF, Murphy-Ullrich JE. Thrombospondin signaling through the calreticulin/LDL receptor-related protein co-complex stimulates random and directed cell migration. J Cell Sci 2003; 14:2917-27.
17. Li SS, Liu Z, Uzunel M, Sundqvist KG. Endogenous thrombospondin-1 is a cell-surface ligand for regulation of integrin-dependent T-lymphocyte adhesion. Blood 2006; 108:3112-20.
18. Liu Z, Christensson M, Forslow A, De Meester I, Sundqvist KG. A CD26-controlled cell surface cascade for regulation of T cell motility and chemokine signals. J Immunol 2009; 183:3616-24.
19. Herz J, Hamann U, Rogne S, Myklebost O, Gausepohl H, Stanley KK. Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor. EMBO J 1988; 7:4119-27.
20. Lillis AP, Van Duyn LB, Murphy-Ullrich JE, Strickland DK. LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies. Physiol Rev 2008; 88:887-918.
21. Cao C, Lawrence DA, Li Y et al. Endocytic receptor LRP together with tPA and PAI-1 coordinates Mac-1-dependent macrophage migration. EMBO J 2006; 25:1860-70.
22. Cheng CF, Fan J, Fedesco M et al. Transforming growth factor α (TGFα)-stimulated secretion of HSP90α: using the receptor LRP-1/CD91 to promote human skin cell migration against a TGFβ-rich environment during wound healing. Mol Cell Biol 2008; 28:3344-58.
23. Mantuano E, Inoue G, Li X, Takahashi K, Gaultier A, Gonias SL, Campana WM. The hemopexin domain of matrix metalloproteinase-9 activates cell signaling and promotes migration of Schwann cells by binding to low-density lipoprotein receptor-related protein. J Neurosci 2008; 28:11571-82.
24. Eriksson C, Rantapaa-Dahlqvist S, Sundqvist KG. T-cell expression of CD91 - a marker of unresponsiveness to anti-TNF therapy in rheumatoid arthritis. APMIS 2010; 118:837-45.
25. Rebres RA, Green JM, Reinhold MI, Ticchioni M, Brown EJ. Membrane raft association of CD47 is necessary for actin polymerization and protein kinase C θ translocation in its synergistic activation of T cells. J Biol Chem 2001; 276:7672-80.
26. Avice MN, Rubio M, Sergerie M, Delespesse G, Sarfati M. Role of CD47 in the induction of human naive T cell anergy. J Immunol 2001; 167:2459-68.
27. - T cells in response to inflammation. J Immunol 2006; 177:3534-41.
28. Li Z, He L, Wilson K, Roberts D. Thrombospondin-1 inhibits TCR-mediated T lymphocyte early activation. J Immunol 2001; 166:2427-36.
29. Orr AW, Pedraza CE, Pallero MA, Elzie CA, Goicoechea S, Strickland DK, Murphy-Ullrich JE. Low density lipoprotein receptor-related protein is a calreticulin coreceptor that signals focal adhesion disassembly. J Cell Biol 2003; 161:1179-89.
30. Haston WS, Shields JM, Wilkinson PC. Lymphocyte locomotion and attachment on two-dimensional surfaces and in three-dimensional matrices. J Cell Biol 1982; 92:747-52.
31. Sundqvist KG, Otteskog P. Anchorage and lymphocyte function: collagen and the maintenance of motile shape in T cells. Immunology 1986; 58:365-9.
32. Schor SL, Allen TD, Winn B. Lymphocyte migration into three-dimensional collagen matrices: a quantitative study. J Cell Biol 1983; 96:1089-96.
33. Wolf K, Muller R, Borgmann S, Brocker EB, Friedl P. Amoeboid shape change and contact guidance: T-lymphocyte crawling through fibrillar collagen is independent of matrix remodeling by MMPs and other proteases. Blood 2003; 102:3262-9.
34. Elsdale T, Bard J. Collagen substrata for studies on cell behavior. J Cell Biol 1972; 54:626-37.
35. Engvall E, Ruoslahti E. Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. Int J Cancer 1977; 20:1-5.
36. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-9.
37. Bidere N, Lorenzo HK, Carmona S, Laforge M, Harper F, Dumont C, Senik A. Cathepsin D triggers Bax activation, resulting in selective apoptosis-inducing factor (AIF) relocation in T lymphocytes entering the early commitment phase to apoptosis. J Biol Chem 2003; 278:31401-11.
38. Sundqvist KG, Wanger L, Ensgstom W. Permissive effect of cytochalasin B on DNA synthesis in concanavalin-A-treated lymphocytes. J Cell Sci 1984; 66:155-66.
39. 2-macroglobulin receptor. J Biol Chem 1991; 266:21232-8.
40. Schultz N, Marenstein DR, De Angelis DA et al. Off-target effects dominate a large-scale RNAi screen for modulators of the TGF-β pathway and reveal microRNA regulation of TGFBR2. Silence 2011; 2:3.
41. Murphy-Ullrich JE, Gurusiddappa S, Frazier WA, Hook M. Heparin-binding peptides from thrombospondins 1 and 2 contain focal adhesion-labilizing activity. J Biol Chem 1993; 268:26784-9.
42. Luo X, Zhang Q, Liu V, Xia Z, Pothoven KL, Lee C. Cutting edge: TGF-β-induced expression of Foxp3 in T cells is mediated through inactivation of ERK. J Immunol 2008; 180:2757-61.
43. Degryse B, Neels JG, Czekay RP, Aertgeerts K, Kamikubo Y, Loskutoff DJ. The low density lipoprotein receptor-related protein is a motogenic receptor for plasminogen activator inhibitor-1. J Biol Chem 2004; 279:22595-604.
44. Gotthardt M, Trommsdorff M, Nevitt MF, Shelton J, Richardson JA, Stockinger W, Nimpf J, Herz J. Interactions of the low density lipoprotein receptor gene family with cytosolic adaptor and scaffold proteins suggest diverse biological functions in cellular communication and signal transduction. J Biol Chem 2000; 275:25616-24.
45. Guttman M, Betts GN, Barnes H, Ghassemian M, van der Geer P, Komives EA. Interactions of the NPXY microdomains of the low density lipoprotein receptor-related protein 1. Proteomics 2009; 9:5016-28.
46. Ma Z, Thomas KS, Webb DJ, Moravec R, Salicioni AM, Mars WM, Gonias SL. Regulation of Rac1 activation by the low density lipoprotein receptor-related protein. J Cell Biol 2002; 159:1061-70.
47. Langlois B, Perrot G, Schneider C, Henriet P, Emonard H, Martiny L, Dedieu S. LRP-1 promotes cancer cell invasion by supporting ERK and inhibiting JNK signaling pathways. PLoS One 2010; 5:e11584.
48. Behbod F, Erwin-Cohen RA, Wang ME et al. Concomitant inhibition of Janus kinase 3 and calcineurin-dependent signaling pathways synergistically prolongs the survival of rat heart allografts. J Immunol 2001; 166:3724-32.
49. Constantin G, Laudanna C, Brocke S, Butcher EC. Inhibition of experimental autoimmune encephalomyelitis by a tyrosine kinase inhibitor. J Immunol 1999; 162:1144-9.
50. Davoodi-Semiromi A, Wasserfall CH, Xia CQ, Cooper-DeHoff RM, Wabitsch M, Clare-Salzler M, Atkinson M. The tyrphostin agent AG490 prevents and reverses type 1 diabetes in NOD mice. PLoS One 2012; 7:e36079.
51. Zhang N, Schroppel B, Lal G et al. Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response. Immunity 2009; 30:458-69.
52. + memory T lymphocytes and the endothelium. J Immunol 2002; 168:3227-34.
53. Crawford SE, Stellmach V, Murphy-Ullrich JE, Ribeiro SM, Lawler J, Hynes RO, Boivin GP, Bouck N. Thrombospondin-1 is a major activator of TGF-β1 in vivo. Cell 1998; 93:1159-70.
54. Velasco P, Huegel R, Brasch J et al. The angiogenesis inhibitor thrombospondin-1 inhibits acute cutaneous hypersensitivity reactions. J Invest Dermatol 2009; 129:2022-30.
55. Malek TR, Pugliese A. Low-dose IL-2 as a therapeutic agent for tolerance induction. Immunotherapy 2011; 3:1281-4.
56. Kamradt T, Goggel R, Erb KJ. Induction, exacerbation and inhibition of allergic and autoimmune diseases by infection. Trends Immunol 2005; 26:260-7.
57. Schneider H, Downey J, Smith A et al. Reversal of the TCR stop signal by CTLA-4. Science 2006; 313:1972-5.
58. Kulkarni AB, Huh CG, Becker D et al. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A 1993; 90:770-4.
59. Shull MM, Ormsby I, Kier AB et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 1992; 359:693-9.
60. + T cells proceeds by several developmentally regulated mechanisms. Int Immunol 2004; 16:501-8.
61. Lee YK, Mukasa R, Hatton RD, Weaver CT. Developmental plasticity of Th17 and Treg cells. Curr Opin Immunol 2009; 21:274-80.